Compare Ferrari NV (RACE) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ferrari NV vs Twist Bioscience Corp — how do they compare? Ferrari NV trades at $371.61 (market cap $65.25B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Ferrari NV is far larger — about 10.9× Twist Bioscience Corp's market cap, and Ferrari NV pays a 1.14% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| RACE | TWST | |
|---|---|---|
Market Cap | $65.25B | $5.97B |
Sector | Consumer Cyclical | Health |
52-Week High | $517.65 | $102.88 |
52-Week Low | $314.63 | $24.16 |
Enterprise Value | $66.46B | $5.89B |
Dividend Yield | 1.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
